| 000 | 01876 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513103431.0 | ||
| 264 | 0 | _c19961120 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0360-3016 | ||
| 024 | 7 |
_a10.1016/s0360-3016(96)00324-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDusenbery, K E | |
| 245 | 0 | 0 |
_aAutologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cSep 1996 |
||
| 300 |
_a335-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aBusulfan _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 700 | 1 | _aSteinbuch, M | |
| 700 | 1 | _aMcGlave, P B | |
| 700 | 1 | _aRamsay, N K | |
| 700 | 1 | _aBlazar, B R | |
| 700 | 1 | _aNeglia, J P | |
| 700 | 1 | _aLitz, C | |
| 700 | 1 | _aKersey, J H | |
| 700 | 1 | _aWoods, W G | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 36 _gno. 2 _gp. 335-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0360-3016(96)00324-0 _zAvailable from publisher's website |
| 999 |
_c8885086 _d8885086 |
||